Hilltop Leaf is a private medicinal cannabis cultivation and extraction business for cannabis based products for medicinal use in humans (CBPMs)
GMP accredited facility focused on creating a science-led Scottish pharmaceutical product while bringing jobs and innovation to the South of Scotland. The company aims to play a leading role in the provision of full spectrum cannabinoid oils, APIs and cannabis based medicinal products.
The beauty of cannabis is that all it is doing is supplementing the body’s natural cannabis system called the endocannabinoid system. Humans, as well as many other animals, have this natural system throughout the body.
The system, in the brain for example, has an effect on memory, control of movement, modulation of pain, development of nerve growth and plasticity, and the adaptability of the nervous system. It has an influence on sleep, appetite, anxiety and social behaviour to name but a few important functions. Outside the brain the endocannabinoid system is also widespread and has effects on the bladder, the bowels, the reproductive system, the heart, the hormonal and metabolic systems and has a role in the control of cancer. In other words, it is one of the most important bodily systems – yet one of the least understood.
We know that there are at least two cannabinoid receptors in the body, CB1 and CB2, but in the next few years we are certain that more receptors will be isolated. There are natural chemicals circulating in the body that attach to these receptors and it is through this chemical attachment that the endocannabinoid system performs its functions. The natural plant cannabinoids are supplementing and assisting the body’s natural circulation of cannabis-like chemicals. Thus, it is not surprising that the plant has many medical benefits.
The plants will be grown in a high security facility with climate controlled conditions. Cultivation to GAcP standards with EU GMP drying and processing.
The extraction facility will be constructed alongside the cultivation within the same high security building. Extraction and Processing facility to EU GMP standards.
We intend to produce a cannabis based medicinal product (CBMP) suitable for specialist prescription to UK patients via our clinical and distribution partners.